Theranos and compliance
One of the most compelling business stories over the past 18 months or so has been that of the Theranos, the developer of a perhaps revolutionary blood testing system, which allegedly allow testing of blood with such a small amount a person would only need their finger pricked. No longer ...
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Article
LendingClub could teach Theranos a thing or two about crisis management
Relatively young, technology-based companies face special difficulties when dealing with crises. Their focus on market disruption and their lack of established credibility make earning public trust even more difficult. And yet, LendingClub shows how it can be done at a time when Theranos certainly failed the crisis management test. David ...
-
WebcastCPE Webcast: Slow Vendors, Changing Risks: The Compliance Customization Gap
A recent survey found that 66% of compliance leaders say their training programs are hard to customize quickly, and nearly half (46%) are being asked to cut training time.
-
WebcastMay 29 | Creating TPRM Stability in an Unsettled World
Wondering how new approaches to age-old regulations affect ethical business practices across your extended enterprise? What about how tariffs may impact your supply chain integrity, and how to best adapt your organization to accelerated shifts in business practices?